Therefore, IgA + B cells exhibit selectivity for MS-associated immunostimulatory bacterial strains and can pass the blood–brain barrier during active multiple sclerosis, according to a follow-up investigation. This evidence concerns the gene CD79A and myeloid sarcoma.